The biologically regulated pathways with significantly different changes in PSRSA vs NRSA involved cytokine‐cytokine receptor interaction, MAPK signalling pathway, melanoma and EGFR tyrosine kinase inhibitor resistance (Figure 4B). Here, EGFR is linked to melanoma.